Warfarin Concept

subject area of

• "Therapeutic range" for oral anticoagulant therapy.  Journal Articles
• Reviews: Use of Warfarin in People with Low Glomerular Filtration Rate or on Dialysis  Journal Articles
• d-Dimer Testing to Determine the Duration of Anticoagulation Therapy  Journal Articles
• A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement  Journal Articles
• A Comparison of Lyophilized Artificially Depleted Plasmas and Lyophilized Plasmas From Patients Receiving Warfarin in Correcting for Coagulometer Effects on International Normalized Ratios  Journal Articles
• A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation  Journal Articles
• A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism  Journal Articles
• A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome  Journal Articles
• A Computer Generated Induction System for Hospitalized Patients Starting on Oral Anticoagulant Therapy  Journal Articles
• A National Survey of Canadian Practice Patterns of Warfarin After Anterior Wall Myocardial Infarction in the Current Era of Dual Antiplatelet Therapy  Journal Articles
• A New, Simplified Measure of Anticoagulation Control With Warfarin: Potential Role in the Direct Oral Anticoagulant Era  Journal Articles
• A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin  Journal Articles
• A Randomized Comparison of a Computer-Based Dosing Program with a Manual System to Monitor Oral Anticoagulant Therapy  Journal Articles
• A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses  Journal Articles
• A Replacement for Warfarin  Journal Articles
• A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score  Journal Articles
• A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)  Journal Articles
• A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system  Journal Articles
• A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis  Journal Articles
• A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation  Journal Articles
• A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program  Journal Articles
• A multicentre randomised clinical endpoint study of parma 5 computer‐assisted oral anticoagulant dosage  Journal Articles
• A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study  Journal Articles
• A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery  Journal Articles
• A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin  Journal Articles
• A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip  Journal Articles
• A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I  Journal Articles
• A review of the oral direct thrombin inhibitor ximelagatran  Journal Articles
• A team-based approach to warfarin management in long term care: A feasibility study of the MEDeINR electronic decision support system  Journal Articles
• ANTICOAGULANTS AFTER OPEN‐HEART SURGERY  Journal Articles
• AUSTRALIAN MULTICENTRE TRIAL OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION  Journal Articles
• Accuracy of a Portable International Normalization Ratio Monitor in Outpatients Receiving Long-Term Oral Anticoagulant Therapy  Journal Articles
• Acquired hemophilia masked by warfarin therapy  Journal Articles
• Activated protein C resistance, factor V Leiden and peripheral vascular disease.  Journal Articles
• Additional Events in the RE-LY Trial  Journal Articles
• Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis  Journal Articles
• Advances in the management of venous thromboembolism  Journal Articles
• Advances in the management of venous thromboembolism.  Journal Articles
• After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding  Journal Articles
• Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation  Journal Articles
• American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy  Journal Articles
• American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.  Journal Articles
• An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial  Journal Articles
• Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients  Journal Articles
• Angina (unstable).  Journal Articles
• Angina (unstable).  Journal Articles
• Angina (unstable).  Journal Articles
• Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation  Journal Articles
• Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients  Journal Articles
• Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome  Conferences
• Anticoagulant-Related Nephropathy  Journal Articles
• Anticoagulants During Pregnancy  Journal Articles
• Anticoagulants and Their Reversal  Journal Articles
• Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease  Journal Articles
• Anticoagulation Therapy  Journal Articles
• Anticoagulation Therapy in Children  Journal Articles
• Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group  Journal Articles
• Anticoagulation for Mechanical Heart Valves  Journal Articles
• Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and End-Stage Renal Disease—First, Do No Harm  Journal Articles
• Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis  Journal Articles
• Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery  Journal Articles
• Anticoagulation of Pregnant Women With Mechanical Heart Valves  Journal Articles
• Anticoagulation therapy in neonates, children and adolescents  Journal Articles
• Anticoagulation therapy in patients with prosthetic heart valves.  Journal Articles
• Anticoagulation therapy in the antiphospholipid syndrome: recent advances  Journal Articles
• Antiphospholipid antibodies and venous thromboembolism  Journal Articles
• Antiphospholipid antibody syndrome  Journal Articles
• Antiphospholipid antibody syndrome: further evidence to guide clinical practice?  Journal Articles
• Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.  Journal Articles
• Antithrombotic Activity of the Novel Oral Anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in Animal Models  Journal Articles
• Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves  Journal Articles
• Antithrombotic therapy in atrial fibrillation.  Journal Articles
• Antithrombotic therapy. Introduction.  Journal Articles
• Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned  Journal Articles
• Approach to the new oral anticoagulants in family practice: part 1: comparing the options.  Journal Articles
• Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials  Journal Articles
• Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.  Journal Articles
• Are older patients with mechanical heart valves at increased risk?  Journal Articles
• Aspirin  Journal Articles
• Aspirin for the Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants  Journal Articles
• Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis  Journal Articles
• Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment—A nationwide register‐based study  Journal Articles
• Atrial Fibrillation and PCI — Do We Still Need Aspirin?  Journal Articles
• Atrial fibrillation in a primary care practice: prevalence and management  Journal Articles
• Atrial mass in a pregnant patient with antiphospholipid antibody syndrome  Journal Articles
• Azathioprine and inhibition of the anticoagulant effect of warfarin: Evidence from a case report and a literature review  Journal Articles
• Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation  Journal Articles
• Barriers and facilitators to optimal oral anticoagulant management: a scoping review  Journal Articles
• Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)  Journal Articles
• Beyond Unfractionated Heparin and Warfarin  Journal Articles
• Beyond heparin and warfarin: the new generation of anticoagulants  Journal Articles
• Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation  Journal Articles
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Journal Articles
• Bleeding events with dabigatran or warfarin in patients with venous thromboembolism  Journal Articles
• Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study  Journal Articles
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Journal Articles
• Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience  Journal Articles
• Bleeding with direct oral anticoagulants vs warfarin: clinical experience  Journal Articles
• Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures  Journal Articles
• Bone marrow biopsy morbidity and mortality: 2002 data.  Journal Articles
• Brand Name versus Generic Warfarin: A Systematic Review of the Literature  Journal Articles
• Bridge Therapy Outcomes in Patients With Mechanical Heart Valves  Journal Articles
• Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design  Journal Articles
• Bridging Anticoagulation  Journal Articles
• Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation  Journal Articles
• Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery  Journal Articles
• Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin  Journal Articles
• Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case  Journal Articles
• Canadian atrial fibrillation anticoaguiation (CAFA) study  Journal Articles
• Canadian atrial fibrillation anticoagulation study: were the patients subsequently treated with warfarin? Canadian Atrial Fibrillation Anticoagulation Study Group.  Journal Articles
• Cardiac Tamponade During Uninterrupted Oral Anticoagulant Therapy for Catheter Ablation for Atrial Fibrillation  Journal Articles
• Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial)  Journal Articles
• Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial  Journal Articles
• Cardioversion of Atrial Fibrillation in ENGAGE AF‐TIMI 48  Journal Articles
• Care of Patients Receiving Long-Term Anticoagulant Therapy  Journal Articles
• Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention  Journal Articles
• Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF  Journal Articles
• Causes of Death and Influencing Factors in Patients With Atrial Fibrillation  Journal Articles
• Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: The need for a balanced approach  Journal Articles
• Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin  Journal Articles
• Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation  Journal Articles
• Changes in Renal Function in Patients With Atrial Fibrillation  Journal Articles
• Changing Paradigms in the Management of Venous Thromboembolism  Journal Articles
• Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial  Journal Articles
• Cimetidine potentiation of warfarin action.  Journal Articles
• Clinical Experience with Anticoagulant Therapy During Pregnancy  Journal Articles
• Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective  Journal Articles
• Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment  Journal Articles
• Clinical factors influencing the sensitivity to warfarin when restarted after surgery  Journal Articles
• Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry  Journal Articles
• Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin  Journal Articles
• Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices  Journal Articles
• Coagulation Assays  Journal Articles
• Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?  Journal Articles
• Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?  Journal Articles
• Comment: Treatment of Heparin-Induced Thrombocytopenia  Journal Articles
• Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole  Journal Articles
• Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study  Journal Articles
• Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol  Journal Articles
• Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study  Journal Articles
• Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study  Journal Articles
• Comparing mortality in patients with atrial fibrillation who are receiving a direct‐acting oral anticoagulant or warfarin: a meta‐analysis of randomized trials  Journal Articles
• Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades  Journal Articles
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conferences
• Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor  Journal Articles
• Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy  Journal Articles
• Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin  Journal Articles
• Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)  Journal Articles
• Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease  Journal Articles
• Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement  Journal Articles
• Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE‐LY trial  Journal Articles
• Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial  Journal Articles
• Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists  Journal Articles
• Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial  Journal Articles
• Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials  Journal Articles
• Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials  Journal Articles
• Complications of long‐term anticoagulation  Journal Articles
• Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation  Journal Articles
• Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial  Journal Articles
• Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial  Journal Articles
• Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting  Journal Articles
• Considerations when prescribing trimethoprim-sulfamethoxazole  Journal Articles
• Contra: “Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery”  Journal Articles
• Controversies in Timing of the First Dose of Anticoagulant Prophylaxis Against Venous Thromboembolism After Major Orthopedic Surgery  Journal Articles
• Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.  Journal Articles
• Cost Effectiveness of Continued-Warfarin Versus Heparin-Bridging Therapy During Pacemaker and Defibrillator Surgery  Journal Articles
• Cost effectiveness of LAA closure in patients with AF and contraindications to warfarin: comment  Journal Articles
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Journal Articles
• Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation  Journal Articles
• Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.  Journal Articles
• Current agents for the treatment of patients with heparin-induced thrombocytopenia  Journal Articles
• D-dimer and factor VIIa in atrial fibrillation – prognostic values for cardiovascular events and effects of anticoagulation therapy  Journal Articles
• DRUG-THERAPY - ORAL ANTICOAGULANT DRUGS  Journal Articles
• Dabigatran Versus Warfarin  Journal Articles
• Dabigatran Versus Warfarin in Patients With Atrial Fibrillation  Journal Articles
• Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation  Journal Articles
• Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?  Journal Articles
• Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial  Journal Articles
• Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE‐LY trial  Journal Articles
• Dabigatran etexilate and reduction in serum apolipoprotein B  Journal Articles
• Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial  Journal Articles
• Dabigatran in Patients with Mechanical Heart Valves  Journal Articles
• Dabigatran in clinical practice: Contemporary overview of the evidence  Journal Articles
• Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation  Journal Articles
• Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II  Journal Articles
• Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.  Journal Articles
• Dabigatran versus Warfarin for Venous Thromboembolism  Journal Articles
• Dabigatran versus Warfarin in Patients with Atrial Fibrillation  Journal Articles
• Dabigatran versus Warfarin in Patients with Mechanical Heart Valves  Journal Articles
• Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism  Journal Articles
• Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada  Journal Articles
• Dabigatran versus warfarin in patients with mechanical heart valves: reply  Journal Articles
• Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study  Journal Articles
• Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients  Journal Articles
• Decreasing warfarin sensitivity during the first three months after heart valve surgery: Implications for dosing  Journal Articles
• Deep Vein Thrombosis: Recovery or Recurrence?  Journal Articles
• Deep vein thrombosis  Journal Articles
• Deep venous thrombosis as a cause of stump swelling in two lower extremity amputee patients.  Journal Articles
• Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department  Journal Articles
• Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum  Journal Articles
• Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis.  Journal Articles
• Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis  Journal Articles
• Device Surgery without Interruption of Anticoagulation  Journal Articles
• Device surgery without interruption of anticoagulation.  Journal Articles
• Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practice  Journal Articles
• Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis  Journal Articles
• Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding  Journal Articles
• Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis  Journal Articles
• Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex  Journal Articles
• Direct Oral Anticoagulants in the Very Elderly  Journal Articles
• Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study  Journal Articles
• Direct and indirect costs of management of long‐term warfarin therapy in Canada  Journal Articles
• Distal Femoral Osteochondroma Masquerading as Deep Vein Thrombosis in an Adolescent Male  Journal Articles
• Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial  Journal Articles
• Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin?  Journal Articles
• Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?  Journal Articles
• Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis  Journal Articles
• Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism  Journal Articles
• Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer  Journal Articles
• Drug–drug interactions with warfarin: A systematic review and meta‐analysis  Journal Articles
• Dual and triple antithrombotic therapies: current patterns of practice and controversies  Journal Articles
• Duration of anticoagulants in acute or recurrent venous thromboembolism  Journal Articles
• EXPERIMENTAL PRODUCTION OF MICROANGIOPATHIC HÆMOLYTIC ANÆMIA IN VIVO  Journal Articles
• Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy  Journal Articles
• Edoxaban and amiodarone: interactions on multiple levels  Journal Articles
• Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves  Journal Articles
• Edoxaban versus Warfarin in Patients with Atrial Fibrillation  Journal Articles
• Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial  Journal Articles
• Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma  Journal Articles
• Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin  Journal Articles
• Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study  Journal Articles
• Effect of non‐vitamin‐K oral anticoagulants on stroke severity compared to warfarin: a meta‐analysis of randomized controlled trials  Journal Articles
• Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes  Journal Articles
• Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism  Journal Articles
• Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events  Journal Articles
• Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi‐database cohort study with meta‐analysis  Journal Articles
• Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min  Journal Articles
• Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state  Journal Articles
• Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism  Journal Articles
• Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism  Journal Articles
• Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1  Journal Articles
• Effects of sodium warfarin administered during pregnancy in mice  Journal Articles
• Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation  Journal Articles
• Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation  Journal Articles
• Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial -  Journal Articles
• Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation  Journal Articles
• Efficacy and Safety of Warfarin VS. Antiplatelet Therapy in Patients with Systolic Heart Failure and Sinus Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Journal Articles
• Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial  Journal Articles
• Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time—A RE-LY trial analysis  Journal Articles
• Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement  Journal Articles
• Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER^®, RE-COVER™ II, and RE-MEDY™  Journal Articles
• Emerging anticoagulants for the treatment of venous thromboembolism  Journal Articles
• Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant—Reply  Journal Articles
• Establishing an Optimal Therapeutic Range for Coumarins  Journal Articles
• Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.  Journal Articles
• Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials  Journal Articles
• Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant  Journal Articles
• Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.  Journal Articles
• Evidence based treatment of the antiphospholipid syndromeII. Optimal anticoagulant therapy for thrombosis  Journal Articles
• Evidence for the Needs of Out-of-Hospital Thrombosis Prophylaxis  Journal Articles
• Exaggerated initial response to warfarin following heart valve replacement  Journal Articles
• Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial  Journal Articles
• Exercise-Induced Deep Vein Thrombosis of the Upper Extremity  Journal Articles
• Extended Anticoagulation in Venous Thromboembolism  Journal Articles
• Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism  Journal Articles
• Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study  Journal Articles
• Extended anticoagulation in venous thromboembolism.  Journal Articles
• Extended anticoagulation in venous thromboembolism.  Journal Articles
• Extended anticoagulation in venous thromboembolism.  Journal Articles
• Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study  Journal Articles
• Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation  Journal Articles
• Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records  Journal Articles
• Fatal heparin‐induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of ‘spontaneous’ HIT?  Journal Articles
• Fetal Effects of Coumadin Administered During Pregnancy  Journal Articles
• Fetal and neonatal outcome of exposure to anticoagulants during pregnancy  Journal Articles
• Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin  Journal Articles
• Gastrointestinal Bleeding With Edoxaban Versus Warfarin  Journal Articles
• Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies  Journal Articles
• Genetic Determinants of Warfarin Maintenance Dose and Time in Therapeutic Treatment Range: A RE-LY Genomics Substudy  Journal Articles
• Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.  Journal Articles
• HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux- induced HIT  Journal Articles
• Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials  Journal Articles
• Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis  Journal Articles
• Heparin-Induced Thrombocytopenia  Journal Articles
• Heparin-Induced Thrombocytopenia  Journal Articles
• Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective  Journal Articles
• Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia  Journal Articles
• Heparin-induced thrombocytopenia and its treatment.  Conferences
• Heparin‐induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery ‘spontaneous’ HIT  Journal Articles
• Higher-risk APS: do we dare to DOAC?  Journal Articles
• Home prophylactic warfarin anticoagulation program after hip and knee arthroplasty.  Journal Articles
• Home-monitoring of oral anticoagulation vs. dabigatran  Journal Articles
• Hospitalization for Hemorrhage Among Warfarin Recipients Prescribed Amiodarone  Journal Articles
• How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism  Journal Articles
• How I treat anticoagulated patients undergoing an elective procedure or surgery  Journal Articles
• How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch  Journal Articles
• How Should Results from Completed Studies Influence Ongoing Clinical Trials?  Journal Articles
• Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients  Journal Articles
• INTERACTION OF IBUPROFEN AND WARFARIN ON PRIMARY HAEMOSTASIS  Journal Articles
• Idrabiotaparinux treatment for venous thromboembolism  Journal Articles
• Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding  Journal Articles
• Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting  Journal Articles
• Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial  Journal Articles
• In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age  Journal Articles
• In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level  Journal Articles
• Inadequate monitoring of warfarin dosage [letter] [see comments]  Journal Articles
• Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy  Journal Articles
• Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study  Journal Articles
• Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism  Journal Articles
• Incidence of Direct Oral Anticoagulant Prescriptions in Kidney Transplant Recipients in Ontario, Canada  Journal Articles
• Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation  Journal Articles
• Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state [see comments]  Journal Articles
• Indirect comparison: relative risk fallacies and odds solution  Journal Articles
• Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale  Journal Articles
• Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation  Journal Articles
• Influence of Warfarin on Symptoms of Fatigue: Findings of a Randomized Trial  Journal Articles
• Influence of low-intensity warfarin treatment on patients' perceptions of quality of life  Journal Articles
• Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial  Journal Articles
• Influenza Vaccination and Vitamin K Antagonist Treatment  Journal Articles
• Inhibition of Warfarin Activity by Ribavirin  Journal Articles
• Intensity and Quality of Warfarin Anticoagulation in Chinese Patients  Journal Articles
• Intensity of Warfarin Coagulation in the Antiphospholipid Syndrome  Journal Articles
• Intensive Initial Oral Anticoagulation and Shorter Heparin Treatment in Deep Vein Thrombosis  Journal Articles
• Interactions of Warfarin with Drugs and Food  Journal Articles
• Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran  Journal Articles
• Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.  Journal Articles
• Intracranial hemorrhage after head injury among older patients on anticoagulation seen in the emergency department: a population-based cohort study  Journal Articles
• Is It Time to Systematically Replace Warfarin With a New Oral Anticoagulant for Higher-Risk Patients With Nonvalvular Atrial Fibrillation?  Journal Articles
• Is the dose of warfarin prescribed by American physicians unnecessarily high?  Journal Articles
• Is the warfarin saga over?  Journal Articles
• Is there really misuse and abuse of dabigatran?  Journal Articles
• Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48  Journal Articles
• Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation  Journal Articles
• Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study  Journal Articles
• Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation  Journal Articles
• Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin  Journal Articles
• Left Atrial Appendage Occlusion Eliminates the Need for Warfarin  Journal Articles
• Limitations of conventional treatment options for heparin-induced thrombocytopenia.  Journal Articles
• Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial  Journal Articles
• Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction  Journal Articles
• Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation?  Conferences
• Long-term anticoagulant therapy - Reply  Journal Articles
• Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation  Journal Articles
• Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event  Journal Articles
• Long‐duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy  Journal Articles
• Long‐term management of venous thromboembolism: is there a role for low‐intensity warfarin therapy?  Journal Articles
• Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation  Journal Articles
• Low-Intensity Adjusted-Dose Warfarin for the Prevention of Hemodialysis Catheter Failure  Journal Articles
• Low-Intensity Warfarin Is Ineffective for the Prevention of PTFE Graft Failure in Patients on Hemodialysis  Journal Articles
• Low-Intensity versus Conventional-Intensity Warfarin for Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients  Journal Articles
• Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin  Journal Articles
• Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer  Journal Articles
• Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial  Journal Articles
• Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin  Journal Articles
• Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10  Journal Articles
• Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review  Journal Articles
• Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin  Journal Articles
• Low-dose warfarin in rehabilitating stroke survivors  Journal Articles
• Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Journal Articles
• Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study  Journal Articles
• Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation  Journal Articles
• Major bleeding risk with warfarin for deep vein thrombosis.  Journal Articles
• Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy  Journal Articles
• Management Of Venous Thromboembolism: Optimization By Clinical Trials  Journal Articles
• Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin  Journal Articles
• Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor  Journal Articles
• Management of Anticoagulation Around Pacemaker and Defibrillator Surgery  Journal Articles
• Management of Anticoagulation before and after Elective Surgery  Journal Articles
• Management of Antiphospholipid Antibody Syndrome  Journal Articles
• Management of Bleeding Complications in the Anticoagulated Patient  Journal Articles
• Management of bleeding complications in patients with cancer on DOACs  Journal Articles
• Management of patients who are receiving warfarin or a new oral anticoagulant and require urgent or emergency surgery  Journal Articles
• Management of venous thromboembolism in cancer patients.  Journal Articles
• Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting  Journal Articles
• Mechanical left atrial appendage closure was noninferior and superior to warfarin in atrial fibrillation  Journal Articles
• Mechanism of Action and Monitoring of Anticoagulants  Journal Articles
• Meeting the Unmet Needs in Anticoagulant Therapy  Journal Articles
• Miconazole Oral Gel Potentiates Warfarin Anticoagulant Activity  Journal Articles
• Microangiopathic Haemolytic Anaemia: the Experimental Production of Haemolysis and Red‐Cell Fragmentation by Defibrination in Vivo  Journal Articles
• Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials  Journal Articles
• Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor  Journal Articles
• Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia  Journal Articles
• Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial  Journal Articles
• Navigating the anticoagulant landscape in 2017  Journal Articles
• Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™  Journal Articles
• New Anticoagulants  Journal Articles
• New anticoagulants in atrial fibrillation management  Conferences
• New anticoagulants: beyond heparin, low‐molecular‐weight heparin and warfarin  Journal Articles
• New developments in anticoagulants: Past, present and future  Journal Articles
• New oral anticoagulant agents – general features and outcomes in subsets of patients  Journal Articles
• New oral anticoagulants in elderly patients  Journal Articles
• New oral anticoagulants: which one should my patient use?  Journal Articles
• Nonadherence with INR Monitoring and Anticoagulant Complications  Journal Articles
• Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study  Journal Articles
• Novel oral anticoagulants in secondary prevention of stroke  Journal Articles
• Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis  Journal Articles
• Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage  Journal Articles
• Optimal intensity and monitoring warfarin  Journal Articles
• Optimal therapeutic level of heparin therapy in patients with venous thrombosis  Journal Articles
• Optimizing warfarin dosing for patients with atrial fibrillation using machine learning  Journal Articles
• Oral Anticoagulant Drugs  Journal Articles
• Oral Anticoagulant Initiation: Rationale for the Use of Warfarin Dosing Nomograms  Journal Articles
• Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease  Journal Articles
• Oral Anticoagulants  Journal Articles
• Oral Anticoagulants  Journal Articles
• Oral Anticoagulants  Journal Articles
• Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range  Journal Articles
• Oral Apixaban for the Treatment of Acute Venous Thromboembolism  Journal Articles
• Oral Rivaroxaban for Symptomatic Venous Thromboembolism  Journal Articles
• Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy  Journal Articles
• Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin  Journal Articles
• Oral anticoagulants in patients with coronary artery disease  Journal Articles
• Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range  Journal Articles
• Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.  Journal Articles
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.  Journal Articles
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.  Journal Articles
• Oral anticoagulation for prolonging survival in patients with cancer  Journal Articles
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation may prolong survival of a subgroup of patients with cancer: a cochrane systematic review  Journal Articles
• Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial  Journal Articles
• Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10  Journal Articles
• Oral vitamin K for warfarin-associated coagulopathy.  Journal Articles
• Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.  Journal Articles
• Oral-anticoagulant-related intracerebral hemorrhage  Journal Articles
• Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials  Journal Articles
• Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events  Journal Articles
• Outcomes and predictors of very stable INR control during chronic anticoagulation therapy  Journal Articles
• Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin  Journal Articles
• Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study  Journal Articles
• Overview of the New Oral Anticoagulants  Journal Articles
• Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation  Journal Articles
• Paper-based dosing algorithms for maintenance of warfarin anticoagulation  Journal Articles
• Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation  Journal Articles
• Parenteral anticoagulation in ambulatory patients with cancer  Journal Articles
• Parenteral anticoagulation in ambulatory patients with cancer  Journal Articles
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Patient education about anticoagulant medication: Is narrative evidence or statistical evidence more effective?  Journal Articles
• Patient outcomes using the European label for dabigatran  Journal Articles
• Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial  Journal Articles
• Patient-reported health preferences of anticoagulant-related outcomes  Journal Articles
• Patients' perspectives on taking warfarin: qualitative study in family practice  Journal Articles
• Patterns and Persistence of Anticoagulant Use in the Treatment of Venous Thromboembolism: Insights from South Korea  Journal Articles
• Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial  Journal Articles
• Perioperative Anticoagulation in Patients with Mechanical Heart Valves Undergoing Elective Surgery: Results of a Survey Conducted among Korean Physicians  Journal Articles
• Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation  Journal Articles
• Perioperative Management of Oral Anticoagulation  Journal Articles
• Perioperative Management of Patients Having Noncardiac Surgery Who Are Receiving Anticoagulant or Antiplatelet Therapy: An Evidence-Based but Practical Approach  Journal Articles
• Perioperative Management of Patients Receiving Anticoagulant or Antiplatelet Therapy: A Clinician-Oriented and Practical Approach  Journal Articles
• Perioperative Management of Patients Receiving Oral Anticoagulants  Journal Articles
• Perioperative Management of Patients Receiving Oral Anticoagulants  Journal Articles
• Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants  Journal Articles
• Perioperative Management of Warfarin Therapy: To Bridge or Not to Bridge, That Is the Question  Journal Articles
• Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.  Journal Articles
• Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians  Journal Articles
• Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure  Journal Articles
• Perioperative management of antithrombotic therapy  Journal Articles
• Perioperative management of apixaban in patients with advanced CKD undergoing a planned invasive procedure  Journal Articles
• Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach  Journal Articles
• Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin  Journal Articles
• Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation  Journal Articles
• Periprocedural Management of Oral Anticoagulation  Journal Articles
• Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants  Journal Articles
• Periprocedural anticoagulation practices in warfarin-treated patients who require elective angiography with or without percutaneous coronary intervention: A retrospective chart review  Journal Articles
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Journal Articles
• Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation  Journal Articles
• Pharmacogenetics of Antiplatelets and Anticoagulants: A Report on Clopidogrel, Warfarin and Dabigatran  Journal Articles
• Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis  Journal Articles
• Pharmacokinetics of direct oral anticoagulants after bariatric surgery: A retrospective cohort study  Journal Articles
• Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.  Journal Articles
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Journal Articles
• Possible Influence of Stroke Etiology on Hemorrhagic Transformation Following Thrombolysis in Warfarin-Treated Patients  Journal Articles
• Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial  Journal Articles
• Post‐thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long‐term cross‐sectional follow‐up of RE‐COVER study patients  Journal Articles
• Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months  Journal Articles
• Practical aspects of new oral anticoagulant use in atrial fibrillation  Journal Articles
• Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure  Conferences
• Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants  Journal Articles
• Practical management of coagulopathy associated with warfarin  Journal Articles
• Practical management of coagulopathy associated with warfarin.  Journal Articles
• Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung  Journal Articles
• Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy  Journal Articles
• Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment  Journal Articles
• Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol  Journal Articles
• Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial  Journal Articles
• Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis  Journal Articles
• Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making  Journal Articles
• Pretreatment of Rabbits With Either Hirudin, Ancrod, or Warfarin Significantly Reduces the Immediate Uptake of Fibrinogen and Platelets by the Deendothelialized Aorta Wall After Balloon-Catheter Injury In Vivo  Journal Articles
• Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran  Journal Articles
• Preventing and managing bleeding complications in anticoagulated patients: A case based approach  Journal Articles
• Prevention of Postthrombotic Syndrome  Journal Articles
• Prevention of Recurrent Venous Thrombosis: Warfarin versus Heparin  Journal Articles
• Prevention of Thromboembolic Events After Bioprosthetic Aortic Valve Replacement  Journal Articles
• Prevention of Venous Thromboembolism After Hip or Knee Arthroplasty  Journal Articles
• Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”  Journal Articles
• Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism  Journal Articles
• Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study  Journal Articles
• Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation  Journal Articles
• Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate  Journal Articles
• Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis  Journal Articles
• Pulmonary hypertension and pregnancy: a series of eight cases  Journal Articles
• Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm  Journal Articles
• Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study  Journal Articles
• Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review  Journal Articles
• Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study  Journal Articles
• RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT  Journal Articles
• Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy  Journal Articles
• Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation  Journal Articles
• Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer  Journal Articles
• Randomized Trial of Warfarin Nomograms  Journal Articles
• Randomized Trial of Warfarin Nomograms  Journal Articles
• Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure  Journal Articles
• Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation  Journal Articles
• Randomized trial of warfarin nomograms.  Journal Articles
• Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation  Journal Articles
• Rates of hemorrhage during warfarin therapy for atrial fibrillation  Journal Articles
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Journal Articles
• Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran  Journal Articles
• Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.  Journal Articles
• Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial  Journal Articles
• Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis  Journal Articles
• Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study  Journal Articles
• Reduced-Intensity Anticoagulation for Mechanical Aortic Valve Prostheses  Journal Articles
• Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial  Journal Articles
• Reducing the risk of recurrent stroke in patients with AF  Journal Articles
• Reliability of the international normalized ratio for monitoring the induction phase of warfarin: Comparison with the prothrombin time ratio  Journal Articles
• Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study  Journal Articles
• Resolving Concerns With the Newer Oral Anticoagulant Medications  Journal Articles
• Response to Letter Regarding Article, “Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study”  Journal Articles
• Response to Letter Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”  Journal Articles
• Response to Letter Regarding Article, “Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin”  Journal Articles
• Response to Letters Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”  Journal Articles
• Response to letter: non‐vitamin‐K oral anticoagulants may not significantly reduce the risk of fatal or disabling stroke compared with warfarin  Journal Articles
• Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.  Journal Articles
• Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality  Journal Articles
• Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage  Journal Articles
• Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply  Journal Articles
• Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management  Journal Articles
• Reversal of Warfarin  Journal Articles
• Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1  Journal Articles
• Reversal of vitamin K antagonist-associated coagulopathy: A survey of current practice  Journal Articles
• Reversible endotension associated with excessive warfarin anticoagulation  Journal Articles
• Reversing Anticoagulant Therapy  Journal Articles
• Reversing anticoagulants both old and new.  Journal Articles
• Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit)  Journal Articles
• Risk factors for MACE and bleeding in atrial fibrillation patients undergoing surgery: Insights from the bridge trial  Journal Articles
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials  Journal Articles
• Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation  Journal Articles
• Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding  Journal Articles
• Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study  Journal Articles
• Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage  Journal Articles
• Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk  Journal Articles
• Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial  Journal Articles
• Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial  Journal Articles
• Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation  Journal Articles
• Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents  Journal Articles
• Safe bridging to warfarin in heparin-induced thrombocytopenia  Journal Articles
• Safer anticoagulant therapy after heart valve replacement  Journal Articles
• Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis  Journal Articles
• Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study  Journal Articles
• Safety of continuing warfarin therapy during cataract surgery: A systematic review and meta-analysis  Journal Articles
• Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists  Journal Articles
• Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review  Journal Articles
• Serial measurement of interleukin‐6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE‐LY trials  Journal Articles
• Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative: HIT or not HIT?  Journal Articles
• Setting a standard for venous thromboembolism prophylaxis  Journal Articles
• Short report: managing anticoagulation. Comparison of results at three primary care centres.  Journal Articles
• Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial  Journal Articles
• Should Warfarin Be Restarted After Warfarin-Associated Intracranial Hemorrhage?  Journal Articles
• Should vitamin K be administered when HIT is diagnosed after administration of coumarin?  Journal Articles
• Side-Effects of COVID-19 on Patient Care: An INR Story  Journal Articles
• Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin  Journal Articles
• Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range  Journal Articles
• Small intestinal bacterial overgrowth and warfarin dose requirement variability  Journal Articles
• Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study  Journal Articles
• Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspective  Journal Articles
• Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial  Journal Articles
• Stroke Prenotification Is Associated with Shorter Treatment Times for Warfarin-Associated Intracerebral Hemorrhage  Journal Articles
• Stroke Prevention in Nonvalvular Atrial Fibrillation  Journal Articles
• Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey  Journal Articles
• Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation  Journal Articles
• Stroke prevention in atrial fibrillation: Closing the gap  Journal Articles
• Structure and function of a perioperative anticoagulation management clinic  Journal Articles
• Studies on the medical treatment of deep vein thrombosis.  Journal Articles
• Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective  Journal Articles
• Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose  Journal Articles
• Substandard monitoring of warfarin in North America. Time for change  Journal Articles
• Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves.  Journal Articles
• Systematic Overview of Warfarin and Its Drug and Food Interactions  Journal Articles
• Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis  Journal Articles
• Tailoring warfarin induction doses to reflect individual and disease-specific factors  Journal Articles
• The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?  Journal Articles
• The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty  Journal Articles
• The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism  Journal Articles
• The Duration of Oral Anticoagulation after Deep Vein Thrombosis  Journal Articles
• The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial  Journal Articles
• The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus  Journal Articles
• The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War?  Journal Articles
• The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations  Journal Articles
• The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia  Journal Articles
• The Pharmacology and Management of the Vitamin K Antagonists  Journal Articles
• The Risk Factors for Thromboembolism in Nonvalvular Atrial Fibrillation and CHADS2 Scoring in Japan  Journal Articles
• The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation  Journal Articles
• The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy  Journal Articles
• The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics  Journal Articles
• The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation  Journal Articles
• The beginning of the end of warfarin?  Journal Articles
• The clinical impact of bleeding during oral anticoagulant therapy  Journal Articles
• The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin  Journal Articles
• The effects of oral anticoagulants in patients with peripheral arterial disease: Rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials  Journal Articles
• The hazards of interrupting anticoagulation therapy in atrial fibrillation  Journal Articles
• The international normalized ratio. A guide to understanding and correcting its problems  Journal Articles
• The management of anticoagulated patients requiring dental extraction: a cross‐sectional survey of oral and maxillofacial surgeons and hematologists  Journal Articles
• The management of congestive heart failure  Journal Articles
• The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study  Journal Articles
• The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation  Journal Articles
• The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.  Journal Articles
• The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants  Journal Articles
• Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared With Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis  Journal Articles
• Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study  Conferences
• Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants  Journal Articles
• Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.  Journal Articles
• Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy  Journal Articles
• Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.  Journal Articles
• Thrombosis and embolism in pediatric cardiomyopathy  Journal Articles
• Thrombosis in Children  Journal Articles
• Thrombotic Complications and Thromboprophylaxis Across All Three Stages of Single Ventricle Heart Palliation  Journal Articles
• Thrombotic Complications of Neonates and Children with Congenital Nephrotic Syndrome  Journal Articles
• Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer  Journal Articles
• Time in therapeutic range: Warfarin anticoagulation for atrial fibrillation in a community-based practice.  Journal Articles
• Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin  Journal Articles
• Transient Global Amnesia as the Presenting Feature of Heparin-Induced Thrombocytopenia  Journal Articles
• Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding  Journal Articles
• Treatment and prophylaxis of venous thromboembolism during pregnancy  Journal Articles
• Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis  Journal Articles
• Treatment of Deep-Vein Thrombosis  Journal Articles
• Treatment of Warfarin-Associated Coagulopathy  Journal Articles
• Treatment of acute pulmonary embolism with dabigatran versus warfarin  Journal Articles
• Treatment of venous thromboembolism with dabigatran  Journal Articles
• Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial  Journal Articles
• Treatment of warfarin-associated coagulopathy with vitamin K  Journal Articles
• Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer  Journal Articles
• Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014  Journal Articles
• Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users  Journal Articles
• Unanswered questions in venous thromboembolism  Journal Articles
• Uncertainty in the minimum event risk to justify treatment was evaluated  Journal Articles
• Underuse of evidence-based warfarin dosing methods for atrial fibrillation patients  Journal Articles
• Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis  Journal Articles
• Upper gastrointestinal haemorrhage following cardiac surgery  Journal Articles
• Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of antithrombotic agents during pregnancy.  Journal Articles
• Use of warfarin (coumarin).  Journal Articles
• Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.  Journal Articles
• Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives  Journal Articles
• Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study  Journal Articles
• Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries  Journal Articles
• Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous Thrombosis  Journal Articles
• Venous Thromboembolism and Cancer  Journal Articles
• Venous Thromboembolism in Older Adults: A Community-based Study  Journal Articles
• Venous limb gangrene and fatal hemorrhage: Adverse consequences of hit “overdiagnosis” in a patient with antiphospholipid syndrome  Journal Articles
• Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin‐induced thrombocytopenia  Journal Articles
• Venous thromboembolism in heparin-induced thrombocytopenia  Journal Articles
• Venous thromboembolism in pregnancy: diagnosis, management and prevention  Journal Articles
• Venous thromboembolism management: where do novel anticoagulants fit?  Journal Articles
• Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation.  Journal Articles
• Vitamin K antagonist reversal strategies: Systematic review and network meta‐analysis from the AABB  Journal Articles
• Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin  Journal Articles
• Vitamin K antagonists and cancer: rebuttal  Journal Articles
• Vitamin K in anticoagulation therapy  Journal Articles
• Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10  Journal Articles
• Warfarin After Bioprosthetic Aortic Valve Implantation  Journal Articles
• Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K  Journal Articles
• Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios  Journal Articles
• Warfarin Interactions With Antibiotics in the Ambulatory Care Setting  Journal Articles
• Warfarin Is the Preferred Therapy for Patients With Thrombotic APS  Journal Articles
• Warfarin Maintenance Dosing Patterns in Clinical Practice  Journal Articles
• Warfarin Prophylaxis in the Antiphospholipid Antibody Syndrome  Journal Articles
• Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis  Journal Articles
• Warfarin Therapy and Risk of Hip Fracture Among Elderly Patients  Journal Articles
• Warfarin Therapy for Atrial Fibrillation: The Patient's Preference Is Important  Journal Articles
• Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial  Journal Articles
• Warfarin and Aspirin after Heart-Valve Replacement  Journal Articles
• Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm  Journal Articles
• Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility  Journal Articles
• Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis  Journal Articles
• Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials  Journal Articles
• Warfarin in Heart Failure  Journal Articles
• Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis  Journal Articles
• Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences.  Journal Articles
• Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty  Journal Articles
• Warfarin-Induced Skin Necrosis in 2 Patients with Protein S Deficiency: Successful Reinstatement of Warfarin Therapy  Journal Articles
• Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome  Journal Articles
• Warfarin‐associated multiple digital necrosis complicating heparin‐induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma‐associated thrombotic endocarditis  Journal Articles
• What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review  Journal Articles
• What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?  Journal Articles
• When guidelines collide  Journal Articles
• When should an effective treatment be used?  Journal Articles
• Which Risk Factors Are More Associated With Ischemic Stroke Than Intracerebral Hemorrhage in Patients With Atrial Fibrillation?  Journal Articles
• Why Do Patients With Atrial Fibrillation Not Receive Warfarin?  Journal Articles
• Withdrawal of warfarin after deep vein thrombosis  Journal Articles
• Work‐related effort thrombosis in a millwright: A case report  Journal Articles
• Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation?  Journal Articles
• Ximelagatran or warfarin in atrial fibrillation?  Journal Articles
• [Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study].  Journal Articles
• [Prothromplex in stead of Beriplex P/N as acute antidote against warfarin].  Journal Articles
• [There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].  Journal Articles
• [Venous thromboembolism, warfarin and cancer--a well-known connection].  Journal Articles
• “Therapeutic Range” for Oral Anticoagulant Therapy  Journal Articles